• Costs for COVID-19 medical services shifted to normal rates and requirements, effective May 12, 2023. This means members covered by U-M health plans will pay regular coinsurance or copays for these services, including charges for using out-of-network providers.
• Also effective May 12, over-the-counter rapid antigen COVID-19 tests are not covered by U-M’s prescription drug plan. Members have through May 2024 to submit reimbursement claims to Magellan Rx for eligible, previously purchased test kits.
• COVID-19 treatment drugs Paxlovid and its generics, nirmatrelvir/ritonavir, will continue to be covered by the U-M prescription drug plan, with no member cost-share as long as the U.S. government pays for these products. 
• COVID-19 vaccinations will continue to be covered at no cost to members.